Business Wire

Michelob Ultra Partners With Lionel Messi to Announce Being Named the Official Global Beer Sponsor of CONMEBOL Copa América USA 2024™

Share

AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD), the world’s leading brewer, and CONMEBOL (Confederación Sudamericana de Fútbol), the governing body of South American football, will elevate their partnership with Michelob Ultra as the Official Global Beer Sponsor of Copa América USA 2024™. This renewed agreement deepens the company’s longstanding commitment to fans around the globe through the world’s most popular sporting events.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231208607579/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Michelob Ultra partners with Lionel Messi to announce being named the Official Global Beer Sponsor of CONMEBOL Copa América USA 2024™ (Photo: Business Wire)

Michelob Ultra is proud to also announce that CONMEBOL Copa América champion and global football icon, Lionel Messi, will be a new brand ambassador. He shared his excitement for the news: “I am so proud to join Michelob Ultra for its activations at CONMEBOL Copa América USA 2024™, such an electrifying moment for our sport. I look forward to the energy the United States fans will bring to the competition and the memorable experiences and atmosphere Michelob Ultra will help create for football teams, players and fans alike.”

The United States will host CONMEBOL Copa América in June and July 2024, a setting which only happens every four years connecting the continent and expanding the tournament to even more fans of the sport. Bringing the tournament to the U.S. will increase the number of participating countries, including offering the U.S. Team entry into the competition, and provides a unique backdrop for spectators amid tremendous growth and excitement for football across North America. Having doubled in volume in five years and the number two beer brand by volume in the U.S., Michelob Ultra is well-positioned to grow alongside the tournament which promises some of the most anticipated matchups between 16 teams representing South, Central and North Americas.

“AB InBev’s partnership with CONMEBOL Copa América and Messi joining Team Ultra is a celebration of our shared passion for football,” said Marcel Marcondes, Chief Marketing Officer of AB InBev. “Football brings people together and is a key passion point for our consumers, we are excited to celebrate our shared passion with global football icon Lionel Messi – a perfect pairing of a superior athlete with our superior light beer.”

“We are pleased with the partnership with AB InBev, a company that aims to provide meaningful experiences to fans by promoting the world's most popular sport. We share the vision of working with a focus on people who enjoy football and doing so with passion and dedication,” stated Alejandro Domínguez, president of CONMEBOL.

Michelob Ultra, along with select local AB InBev brands, will support the tournament with cohesive brand experiences across participating countries. In the U.S., the brand will be integrated into stadium and training facilities, host special activations at Fan Fest events, as well as the Superior Player of the Match Trophy and locker room celebrations.

For more on AB InBev, follow us on LinkedIn, Twitter, Facebook and Instagram and for more on Copa América USA 2024™, follow them on Twitter, Facebook, Instagram, TikTok and YouTube.

About Anheuser-Busch InBev
Anheuser-Busch InBev (AB InBev) is a publicly traded company (Euronext: ABI) based in Leuven, Belgium, with secondary listings on the Mexico (MEXBOL: ANB) and South Africa (JSE: ANH) stock exchanges and with American Depositary Receipts on the New York Stock Exchange (NYSE: BUD). As a company, we dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, move our industry forward and make a meaningful impact in the world. We are committed to building great brands that stand the test of time and to brewing the best beers using the finest ingredients. Our diverse portfolio of well over 500 beer brands includes global brands Budweiser®, Corona® and Stella Artois®; multi-country brands Beck’s®, Hoegaarden®, Leffe® and Michelob ULTRA®; and local champions such as Aguila®, Antarctica®, Bud Light®, Brahma®, Cass®, Castle®, Castle Lite®, Cristal®, Harbin®, Jupiler®, Modelo Especial®, Quilmes®, Victoria®, Sedrin®, and Skol®. Our brewing heritage dates back more than 600 years, spanning continents and generations. From our European roots at the Den Hoorn brewery in Leuven, Belgium. To the pioneering spirit of the Anheuser & Co brewery in St. Louis, US. To the creation of the Castle Brewery in South Africa during the Johannesburg gold rush. To Bohemia, the first brewery in Brazil. Geographically diversified with a balanced exposure to developed and developing markets, we leverage the collective strengths of approximately 167,000 colleagues based in nearly 50 countries worldwide. For 2022, AB InBev’s reported revenue was 57.8 billion USD (excluding JVs and associates).

About CONMEBOL
The Confederación Sudamericana de Fútbol, better known as CONMEBOL (which comes from the acronym used in cable releases: Confederación Sudamericana de Fútbol), is the confederation of national football associations (federations) of South America. Founded on July 9, 1916 in Buenos Aires, it is the first Confederation in the world, established almost 40 years before the next ones to be formed. CONMEBOL originated from a tournament between countries of the South American continent. The first Copa América was held in 1916 in Buenos Aires in celebration of the hundred years of Argentina's independence. This was the beginning of the institution, originally composed of the associations of Argentina, Brazil, Chile and Uruguay. Later on, the other South American associations joined CONMEBOL: Paraguay (1921), Peru (1925), Bolivia (1926), Ecuador (1927), Colombia (1936) and Venezuela (1953). It is the only soccer confederation in which all its associations are also members of FIFA and the International Olympic Committee (IOC). Its ten member National Associations are the pride of CONMEBOL.

About CONMEBOL Copa América 2024™
The CONMEBOL Copa América 2024™ will be played in the United States and includes 10 CONMEBOL teams and 6 guest teams from Concacaf. This traditional tournament is organized by both confederations. Concacaf’s 6 teams will qualify through the 2023/24 Concacaf Nations League. At the conclusion of the Group Stage, the League A group winners and runners-up then advance to the Quarterfinals, where they were paired with the four top ranked Concacaf Nations, resulting in the following matchups: Mexico vs Honduras, United States vs Trinidad and Tobago, Canada vs Jamaica, and Costa Rica vs Panama. The Quarterfinals, played November 16-21, will be decided via aggregate score and the winner of each matchup will qualify for the CONMEBOL Copa América 2024. The remaining two Concacaf participants will be decided by a Play-In match between the losing quarterfinalists. This Play-In will take place in March 2024. In its 48th edition of one of the most important competitions on the continent, this will be the second time in the tournaments history that it will host 16 teams – having hosted the same number of teams in its 2016 edition, also held in the United States. Taking the field will be 10 South American FIFA World Cup™ title holders and the biggest stars in world soccer to play 32 matches in this edition of the tournament in June and July 2024.

About Rocking the Continent
The CONMEBOL Copa América™ has an incredible power, it can make everything move, it makes emotions vibrate and hearts soar. It makes the flags fly, the nets shake, the stands, and the stadiums tremble. Its history makes the entire continent proud, and our soccer beats with a united force. This competition has the power to bring out the best version of what we are: soccer, history, joy, and passion.

#VibraElContinente

Legal disclaimer
This release contains “forward-looking statements”. These statements are based on the current expectations and views of future events and developments of the management of AB InBev and are naturally subject to uncertainty and changes in circumstances. The forward-looking statements contained in this release include statements other than historical facts and include statements typically containing words such as “will”, “may”, “should”, “believe”, “intends”, “expects”, “anticipates”, “targets”, “estimates”, “likely”, “foresees” and words of similar import. All statements other than statements of historical facts are forward-looking statements. You should not place undue reliance on these forward-looking statements, which reflect the current views of the management of AB InBev, are subject to numerous risks and uncertainties about AB InBev and are dependent on many factors, some of which are outside of AB InBev’s control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different including, but not limited to, the effects of the COVID-19 pandemic and uncertainties about its impact and duration and the risks and uncertainties relating to AB InBev described under Item 3.D of AB InBev’s Annual Report on Form 20-F filed with the SEC on 18 March 2022. Many of these risks and uncertainties are, and will be, exacerbated by the COVID-19 pandemic and the ongoing conflict in Russia and Ukraine and any worsening of the global business and economic environment as a result. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements should be read in conjunction with the other cautionary statements that are included elsewhere, including AB InBev’s most recent Form 20-F and other reports furnished on Form 6-K, and any other documents that AB InBev has made public. Any forward-looking statements made in this communication are qualified in their entirety by these cautionary statements and there can be no assurance that the actual results or developments anticipated by AB InBev will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, AB InBev or its business or operations. Except as required by law, AB InBev undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

AB InBev Media Relations
media.relations@ab-inbev.com

CONMEBOL Media Relations
prensa@conmebol.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IFF Announces Grant of Employment Inducement Awards1.3.2024 22:15:00 CET | Press release

IFF (NYSE: IFF) today announced the grant of employment inducement awards to J. Erik Fyrwald, IFF Chief Executive Officer and member of the Board of Directors. The Company's Board of Directors approved the employment inducement awards on Jan. 9, 2024, with a grant date of March 1, 2024, as a material inducement to enter into an offer of employment in reliance on the employment inducement award exception to New York Stock Exchange Listing Rule 303A.08 that requires shareholder approval of equity-based compensation plans. Listing Rule 303A.08 requires the public announcement of such an award. The inducement awards will consist of (i) a target award of 68,750 performance share units (with a maximum award of 171,875 performance share units), subject to meeting the applicable performance targets set forth in the award agreement, and (ii) 56,250 restricted stock units, 100% of which will vest on the three-year anniversary of the grant date, for a maximum potential combined payout of 228,125

Whitehorse Liquidity Partners Recognized by Private Equity International’s 2023 Awards1.3.2024 16:30:00 CET | Press release

Whitehorse Liquidity Partners (together with its advisory affiliates, “Whitehorse”), a specialized investment manager focused on providing structured liquidity solutions to the alternative asset class, is pleased to announce recognition from Private Equity International (PEI) in the 2023 PEI Awards. Whitehorse placed third in the Secondaries Firm of the Year in the Americas category alongside Blackstone Strategic Partners and HarbourVest Partners and was voted Firm of the Year in Canada. “We are honoured to have been recognized again in two categories by the PEI Awards,” said Yann Robard, Managing Partner of Whitehorse. “For the fourth time among the top three Secondaries Firm of the Year in the Americas category (2018, 2020, 2022 and 2023) and the sixth time among the top three in the Firm of the Year in Canada category (2017, 2018, 2020, 2021, 2022 and 2023). You often hear us say that big is beautiful, growth is good and scale matters. Our scale has enabled us, not disrupted us. We

Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign1.3.2024 14:30:00 CET | Press release

Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. (NYSE: PVH), and Calvin Klein Fragrances, a division of Coty Inc. (NYSE: COTY), today unveil actor and musician Idris Elba and his wife, model and human rights activist Sabrina Elba as the faces of Calvin KleinETERNITY AROMATIC ESSENCE, the newest addition to the ETERNITYfragrance portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301420936/en/ Calvin Klein Fragrances announces Idris and Sabrina Elba as the face of new Calvin Klein ETERNITY AROMATIC ESSENCE fragrance campaign (Photo: Business Wire) Shot by Mert Alas, the campaign offers a fresh and impactful take on ETERNITY’s timeless dream of eternal love, capturing Idris and Sabrina in moments of intimacy set to a bespoke cover of “Fever” by FKA twigs. The striking campaign imagery is inspired by profound connection and the essence of desire, paying tribute to ETERNITY’s legacy of sensuality by partnerin

Wellness Market Leaders Join Forces: The DRIPBaR Powered by REVIV1.3.2024 13:35:00 CET | Press release

The DRIPBaR, recognized as the fastest-growing IV therapy franchise in the United States, has joined forces with REVIV, the global leader in IV therapy, marking a significant milestone for the industry. The partnership creates an unrivaled offering by bringing together the specialties of two industry heavyweights boasting over 200 locations across 6 continents, with plans to add thousands more locations in the coming years. The recent surge in demand for IV therapy presents enormous opportunities globally for the companies to redefine industry standards and spearhead the next era of IV therapy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240301173923/en/ Ben Crosbie, CEO of The DRIPBaR and Sarah Lomas, Founder and CEO of REVIV Global, announce their exciting partnership. (Photo: Business Wire) With an extensive pipeline boasting over 450 franchisees in the United States, The DRIPBaR's decision to integrate REVIV's proprie

GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to Commercialize cemiplimab in Greece, Cyprus and Malta1.3.2024 09:37:00 CET | Press release

GENESIS Pharma, a regional biopharma company specialized in the commercialization of innovative medicines targeting severe and rare diseases in Central and Eastern Europe, announces an exclusive distribution agreement for the cancer medicine cemiplimab in Greece, Cyprus and Malta with Regeneron Ireland DAC. Regeneron Ireland DAC is a wholly owned subsidiary of Regeneron, a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Cemiplimab is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune® technology. In the European Union, cemiplimab is indicated for adults as monotherapy treatment for certain patients with locally advanced or metastatic basal cell carcinoma (BCC), as monotherapy treatment for certain patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC), as both monotherapy o

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye